Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
Thomson
Essential Science Indicators - Special Topics  RSS feeds for the editorial Web sites of Essential Science Indicators.
All Topics Menu
Help || About || Contact

  
|  Previous Page  |
  |  Special Topics Menu  |  |  Next Page  |
  

ESI Special Topic of:
"Coronaviruses," Published June 2003

•> Search Special Topics
Coronaviruses Menu

Coronaviruses

An INTERVIEW with Stanley Perlman, Ph.D., M.D.

ESI Special Topics, July 2003
Citing URL - http://www.esi-topics.com/coronavirus/interviews/StanleyPerlman.html

In this interview for Special Topics, Dr. Stanley Perlman of the University of Iowa discusses his highly cited work on coronaviruses. In our analysis, Dr. Perlman ranks at #8 among scientists publishing in this topic over the past decade, with 36 papers cited a total of 473 times. Dr. Perlman is a Professor of Pediatrics and Microbiology at the Roy J. and Lucille A. Carver College of Medicine of the University of Iowa.

ST:  Why do you think your work is highly cited?

We study infections in the central nervous system of mice caused by mouse hepatitis virus and the host immune response to these infections. A consequence of the anti-viral host immune response is destruction of the myelin sheath within the white matter of the spinal cord. This results in demyelination with a disease pattern similar to that observed in humans with multiple sclerosis. This model has been useful for understanding some of the features of multiple sclerosis that are not amenable to observation in humans. Our work has identified several unique aspects of this immunopathological process. We have identified variants of the virus that are able to evade virus-specific cytotoxic T cells (CTL escape mutants). CTL escape mutants have been identified in several human infections, including those caused by hepatitis C virus and HIV. Our model is one of the best animal models for studying CTL escape. Second, we have developed model systems that allow us to delineate the precise effector molecules involved in demyelination. Delineation of these factors is important not only for understanding the pathogenesis of the disease but also for future development of therapeutic agents for multiple sclerosis and other related diseases.

ST:  Please describe the significance of your work on coronaviruses in layman's terms.

This research is significant in understanding how coronaviruses are able to persist after infection of humans or animals. As the host tries to clear the infection, the result is destruction of parts of the central nervous system. This results in symptoms similar to those observed in patients with multiple sclerosis. Similar pathological changes may occur in humans infected with the SARS-related coronavirus, since widespread destruction of the lungs is apparent in some infected people, without much evidence for the virus still being present.

ST:  How did you become involved in this research?

After completing medical school and a pediatric residency, I became interested in understanding how viruses and the host immune response to these viruses affect the central nervous system. Mice infected with mouse hepatitis virus serve as an excellent model for investigating these issues.

ST:  Has the current concern about SARS affected the course of your research?

It has certainly made coronavirus research in general more timely. Previously, we considered our work as relevant for understanding how viruses persist in the central nervous system and the immunopathological consequences of these infections. We are now partly shifting our focus to understanding how the SARS-related coronavirus causes disease in infected humans. There may be both direct viral affects of the infection as well as disease caused by the host immune response to the virus; we are interested in both aspects. Ultimately, of course, we would like to make a contribution to removing this virus as a threat to humans.

ST:  How important are these viruses in human disease?

Before the SARS epidemic began, these viruses were notable for causing 15-25% of upper respiratory tract infections, and possibly for occasionally causing small epidemics of diarrhea. They were associated with several important diseases of livestock but not so much with human disease.

Where do you see this research going 10 years from now?

If SARS turns out to be a persistent and important problem, I think that much effort will be made to understand the pathogenesis of the disease and to develop anti-viral agents and vaccines that will be useful in preventing and treating the disease. While we will work on the SARS-related coronavirus, I think that efforts to understand the immunopathological diseases caused by the murine coronaviruses will continue to occupy much of our efforts, since these models are very useful for understanding many diseases with chronic inflammation, most notably multiple sclerosis.

ST:  What lessons would you draw from your work to share with the next generation of researchers?

Coronaviruses have been labeled a backwater virus and the relevance of the study of these viruses to understanding human disease has been questioned in the past. However, the SARS epidemic shows that it is difficult to know with certainty which lines of investigation will be most important in the future. Therefore, young investigators should work in areas that they find interesting and pursue investigations that lead to novel information, even if they do not seem immediately relevant to understanding human disease.End

Stanley Perlman, Ph.D., M.D.
University of Iowa
Iowa City, Iowa, USA

ESI Special Topics, July 2003
Citing URL - http://www.esi-topics.com/coronavirus/interviews/StanleyPerlman.html

ESI Special Topic of:
"Coronaviruses," Published June 2003

•> Search Special Topics
Coronaviruses Menu || All Topics Menu ||
Interview Index
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.